Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) EV to EBIT (2013 - 2017)

Updated

Mosaic ImmunoEngineering's (CPMV) EV to EBIT stood at 45044.55 in Q1 2018.

Analysis

Mosaic ImmunoEngineering (CPMV) EV to EBIT (2013 - 2017) Analysis & Trends

On a TTM basis, Mosaic ImmunoEngineering's EV to EBIT came in at 44799.67 as of Aug 31, 2017; for FY2013, it was 19246.71.

  • The Q1 2018 figure is the highest quarterly EV to EBIT since Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2017 45,044.55
Feb 28, 2014 12,358.50
Nov 30, 2013 65,238.85
Aug 31, 2013 15,929.87
May 31, 2013 19,246.71
API Access

Mosaic ImmunoEngineering EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CPMV&period=max&api_key=YOUR_API_KEY